CVRx Inc. (CVRX)
NASDAQ: CVRX
· Real-Time Price · USD
7.71
-0.11 (-1.41%)
At close: Sep 04, 2025, 3:05 PM
-1.41% (1D)
| Bid | 5.64 |
| Market Cap | 201.63M |
| Revenue (ttm) | 54.65M |
| Net Income (ttm) | -52.25M |
| EPS (ttm) | -2.06 |
| PE Ratio (ttm) | -3.74 |
| Forward PE | -4.09 |
| Analyst | Buy |
| Ask | 9.33 |
| Volume | 122,310 |
| Avg. Volume (20D) | 248,256 |
| Open | 7.90 |
| Previous Close | 7.82 |
| Day's Range | 7.56 - 7.90 |
| 52-Week Range | 4.30 - 18.55 |
| Beta | 1.23 |
About CVRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CVRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CVRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CVRx Inc. is scheduled to release its earnings on
Oct 28, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-9.8%
CVRx shares are trading lower after the company re...
Unlock content with
Pro Subscription
1 month ago
+19.01%
CVRx shares are trading higher after the company announced its Barostim implant implant is set for a $45,000 medicare reimbursement for procedures performed in the outpatient setting.
